These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 12769695)
1. Crystallography of membrane proteins, major targets in drug design. Wouters J Mini Rev Med Chem; 2003 Aug; 3(5):439-48. PubMed ID: 12769695 [TBL] [Abstract][Full Text] [Related]
2. The 3.1 A X-ray crystal structure of the integral membrane enzyme prostaglandin H2 synthase-1. Garavito RM; Picot D; Loll PJ Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():99-103. PubMed ID: 7732912 [No Abstract] [Full Text] [Related]
3. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Picot D; Loll PJ; Garavito RM Nature; 1994 Jan; 367(6460):243-9. PubMed ID: 8121489 [TBL] [Abstract][Full Text] [Related]
4. Structural biology: The gatekeepers revealed. Baker M Nature; 2010 Jun; 465(7299):823-6. PubMed ID: 20535212 [No Abstract] [Full Text] [Related]
5. G-protein-coupled receptors in drug discovery--seventh annual Informa conference. Part 1--GPCR structures and ligand binding. Jockers R IDrugs; 2009 May; 12(5):285-8. PubMed ID: 19431090 [No Abstract] [Full Text] [Related]
6. Crystal structure of human monoamine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane. Binda C; Hubálek F; Li M; Edmondson DE; Mattevi A FEBS Lett; 2004 Apr; 564(3):225-8. PubMed ID: 15111100 [TBL] [Abstract][Full Text] [Related]
7. Serial Femtosecond Crystallography of Membrane Proteins. Zhu L; Weierstall U; Cherezov V; Liu W Adv Exp Med Biol; 2016; 922():151-160. PubMed ID: 27553241 [TBL] [Abstract][Full Text] [Related]
8. The family of G protein-coupled receptors: an example of membrane proteins. Tikhonova IG; Fourmy D Methods Mol Biol; 2010; 654():441-54. PubMed ID: 20665280 [TBL] [Abstract][Full Text] [Related]
9. Structure-guided applications in drug discovery. Wyss DF Drug Discov Today; 2003 Oct; 8(20):924-6. PubMed ID: 14554155 [No Abstract] [Full Text] [Related]
10. Structure-based design in the GPCR target space. Kontoyianni M; Liu Z Curr Med Chem; 2012; 19(4):544-56. PubMed ID: 22204332 [TBL] [Abstract][Full Text] [Related]
11. The structure of mammalian cyclooxygenases. Garavito RM; Mulichak AM Annu Rev Biophys Biomol Struct; 2003; 32():183-206. PubMed ID: 12574066 [TBL] [Abstract][Full Text] [Related]
12. GPCR structures in drug design, emerging opportunities with new structures. Tautermann CS Bioorg Med Chem Lett; 2014 Sep; 24(17):4073-9. PubMed ID: 25086683 [TBL] [Abstract][Full Text] [Related]
16. Structures of class B G protein-coupled receptors: prospects for drug discovery. Hausch F Angew Chem Int Ed Engl; 2013 Dec; 52(49):12783-5. PubMed ID: 24127232 [TBL] [Abstract][Full Text] [Related]
17. Potential for the Rational Design of Allosteric Modulators of Class C GPCRs. Christopher JA; Doré AS; Tehan BG Curr Top Med Chem; 2017; 17(1):71-78. PubMed ID: 27448651 [TBL] [Abstract][Full Text] [Related]
18. Overcoming the challenges of membrane protein crystallography. Carpenter EP; Beis K; Cameron AD; Iwata S Curr Opin Struct Biol; 2008 Oct; 18(5):581-6. PubMed ID: 18674618 [TBL] [Abstract][Full Text] [Related]
20. The use of GPCR structures in drug design. Congreve M; Langmead C; Marshall FH Adv Pharmacol; 2011; 62():1-36. PubMed ID: 21907905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]